Contract Service Directory

Hetero USA Inc.





Company Headquarters

1031 Centennial Avenue
Piscataway, NJ 08854
United States

Contract Service Directory

    Related Content

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Discovery | Facilities | Industry News | R&D
       CordenPharma & GE Healthcare in Drug Development Pact

      CordenPharma & GE Healthcare in Drug Development Pact

      Enter collaboration to meet customer need for a simplified, faster development process
      06.30.17

    • APIs
      Optimizing the API Life Cycle Through Innovation

      Optimizing the API Life Cycle Through Innovation

      Bringing down API costs through new technologies and customer collaboration
      Jonathan Knight, VP New Product Development, Cambrex 06.06.17

    • Biologics, Proteins, Vaccines | Fill/Finish | Injectables | Parenterals
      Newsmakers: Joanne Anderson

      Newsmakers: Joanne Anderson

      Scottish CMO Sets Up Shop in U.S.
      06.06.17


    • Breaking News | Facilities | Industry News | Serialization
      Optel Opens Site in Brazil

      Optel Opens Site in Brazil

      South America’s largest economy is in the process of implementing serialization legislation
      06.05.17

    • Breaking News | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
      Dow Offers New Technology to Solve Pharma Challenges

      Dow Offers New Technology to Solve Pharma Challenges

      Company’s silicone chemistries target cost control, product differentiation and solubility challenges
      05.17.17

    • Clinical Trial Materials
      CMO Selection Criteria

      CMO Selection Criteria

      What should sponsors look for when outsourcing manufacture of material for first in human studies?
      Alastair Hay 05.09.17


    • Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
      Altor BioScience and CMC Biologics Team Up

      Altor BioScience and CMC Biologics Team Up

      CMC to manufacture and validate Altor’s IL-15 superagonist molecule, ALT-803, for use in Phase 3 trials
      04.18.17

    • Analytical Services
      Quality Risk Management

      Quality Risk Management

      It’s not just for the big guys anymore
      Emil W. Ciurczak, DoraMaxx Consulting 04.03.17

    • cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News | Solid Dosage/Creams/Ointments

      Pfizer CentreOne Expands Service Portfolio

      Adds contract manufacturing of highly potent solid oral dose at Ireland facility
      03.16.17


    • Capsules | Solid Dosage/Semi-solids
      Oral Solid Dose and the Psychology of Appearance

      Oral Solid Dose and the Psychology of Appearance

      Improved drug delivery and understanding patient needs are driving innovation in today’s oral solid dose market
      Emilie Branch, Scientific Content Manager 03.07.17

    • Solid Dosage/Semi-solids
      Oral Solid Dosage Outsourcing: Trends & Challenges

      Oral Solid Dosage Outsourcing: Trends & Challenges

      Despite the increasing number of biologics, oral solids remain the dominant dosage form in the pharmaceutical market.
      Tim Wright, Editor, Contract Pharma 03.07.17

    • Regulatory Affairs | Serialization
      DSCSA Serialization: It’s Not Too Late

      DSCSA Serialization: It’s Not Too Late

      If you’re not yet compliant with DSCSA, here are some practical steps to follow
      John Jordon and Vito Pirrera, Vantage Consulting Group 03.07.17


    • GMPs/GCPs | Inspections | QA/QC | Regulatory Affairs | Validation

      Compliance Challenges

      The importance of contract compliance during regulatory change
      Bill Adams, SC&H Group 01.26.17

    • Chemistry | Collaborations & Alliances | Drug Discovery

      Enamine, Actelion Expand Drug Discovery Collaboration

      Enamine to provide library synthesis and medicinal chemistry services
      01.23.17